13F Pro

SEC Form 4 reporting owner

Randhawa Simrat

Randhawa Simrat has filed 19 Form 4 transactions reported between February 3, 2026 and September 1, 2026, as EVP, Head of R&D of Dianthus Therapeutics, Inc. /DE/.

Name as filed: Randhawa Simrat

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
$7.6M
7 lines
Companies
1
with Form 4 filings
Latest transaction
Sep 1, 2026
transaction date

Roles and reported holdings

  • DNTHDianthus Therapeutics, Inc. /DE/
    Feb 3, 2026 – Sep 1, 2026

    EVP, Head of R&D

    Held directly4,000 sh as of Sep 1, 2026 · Form 4

    24 months: $7.6M sold

Transaction history

All 19 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Sep 1, 2026DNTHEVP, Head of R&DOpen-market saleCode S · direct13,309$1.4M@ $106.74Form 4
Sep 1, 2026DNTHEVP, Head of R&DOpen-market saleCode S · direct7,215$767K@ $106.25Form 4
Sep 1, 2026DNTHEVP, Head of R&DOpen-market saleCode S · direct2,600$273K@ $105.19Form 4
Sep 1, 2026DNTHEVP, Head of R&DOption exerciseCode M · direct9,375$207K@ $22.07Form 4
Sep 1, 2026DNTHEVP, Head of R&DOption exerciseCode M · direct6,249$136K@ $21.77Form 4
Sep 1, 2026DNTHEVP, Head of R&DOption exerciseCode M · direct7,500$134K@ $17.88Form 4
Jun 1, 2026DNTHEVP, Head of R&DOpen-market saleCode S · direct4,159$380K@ $91.37Form 4
Jun 1, 2026DNTHEVP, Head of R&DOpen-market saleCode S · direct16,943$1.5M@ $90.72Form 4
Jun 1, 2026DNTHEVP, Head of R&DOpen-market saleCode S · direct5,428$487K@ $89.72Form 4
Jun 1, 2026DNTHEVP, Head of R&DOption exerciseCode M · direct9,375$207K@ $22.07Form 4
Jun 1, 2026DNTHEVP, Head of R&DOption exerciseCode M · direct6,249$136K@ $21.77Form 4
Jun 1, 2026DNTHEVP, Head of R&DOption exerciseCode M · direct6,908$124K@ $17.88Form 4
Jun 1, 2026DNTHEVP, Head of R&DOption exerciseCode M · direct3,998$34K@ $8.44Form 4
Mar 12, 2026DNTHEVP, Head of R&DOpen-market saleCode S · direct33,830$2.8M@ $81.48Form 4
Mar 12, 2026DNTHEVP, Head of R&DOption exerciseCode M · direct12,500$276K@ $22.07Form 4
Mar 12, 2026DNTHEVP, Head of R&DOption exerciseCode M · direct8,332$181K@ $21.77Form 4
Mar 12, 2026DNTHEVP, Head of R&DOption exerciseCode M · direct5,000$89K@ $17.88Form 4
Mar 12, 2026DNTHEVP, Head of R&DOption exerciseCode M · direct7,998$68K@ $8.44Form 4
Feb 3, 2026DNTHEVP, Head of R&DGrant or awardCode A · direct150,000—Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.